Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.48 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | XIAP | P98170 | 1/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 4/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.36 |
| ▸ | GRIA3 | P42263 | 3/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL18047802 | 1.00 | PTGS1 (0.48) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL851432 | 1.00 | PTGS1 (0.48) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL22091426 | 1.00 | PTGS1 (0.48) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL27769589 | 1.00 | PTGS1 (0.48) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL4452747 | 1.00 | PTGS1 (0.48) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL28655326 | 0.98 | PTGS1 (0.47) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL28511880 | 0.98 | PTGS1 (0.47) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL28203991 | 0.98 | PTGS1 (0.47) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL1692193 | 0.98 | PTGS1 (0.47) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 | |
| Histidine SCHEMBL1257407 | 0.94 | PTGS1 (0.43) | PTGS1SLC7A11SLC7A5CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114558029-A | Copper cluster, thymine modified hyaluronic acid and poly-copper cluster, and preparation method and application thereof | 武汉广行科学研究有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-109939243-A | Copper cluster, thymine modified hyaluronic acid and poly-copper cluster, and preparation method and application thereof | 深圳广行科学研究有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-109022381-A | Amino acid dehydrogenase mutant and its application | 凯莱英生命科学技术(天津)有限公司 | 2018-12-18 | — | — | CN | claimed |
| WO-2003099322-A2 | IL-11 DERIVATIVES AND THERAPEUTIC USES THEREOF | ISIS INNOVATION LIMITED (GB) | 2003-12-04 | — | — | WO | claimed |
| EP-0829206-A1 | Edible micro-emulsion for coating food products and its use for browning and crisping in a microwave | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1998-03-18 | — | — | EP | claimed |
| EP-0769549-A2 | Enzyme mutants having a low degree of variation of the molecular charge over a pH range | NOVO NORDISK A/S (DK) | 1997-04-23 | — | — | EP | claimed |
| WO-1992011357-A1 | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE | NOVO NORDISK A/S (DK) | 1992-07-09 | — | — | WO | claimed |
| US-20240238443-A1 | Application of AuCs or Substances Containing AuCs in the Preparation of Drugs for Preventing and/or Treating Glaucoma | Shenzhen Profound-View Pharma Tech Co., Ltd (CN) | 2024-07-18 | — | — | US | disclosed |
| WO-2024117904-A1 | RECEPTOR- AND DRUG-DEPENDENT REGULATED ON-SITE PRODUCTION OF BIOLOGICALS | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis (NL) | 2024-06-06 | — | — | WO | disclosed |
| EP-4372090-A2 | CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING GRNAS | Editas Medicine, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-114940713-B | Anti-TRKB antibodies | 清华大学 | 2024-04-30 | — | — | CN | disclosed |
| US-11969477-B2 | Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma | Shenzhen Profound-View Pharma Tech Co., Ltd (CN) | 2024-04-30 | — | — | US | disclosed |
| US-20240132916-A1 | NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-04-25 | — | — | US | disclosed |
| EP-0787186-A1 | NEURONAL APOPTOSIS INHIBITOR PROTEIN, GENE SEQUENCE AND MUTATIONS CAUSATIVE OF SPINAL MUSCULAR ATROPHY | UNIVERSITY OF OTTAWA (CA) | 1997-08-06 | — | — | EP | disclosed |
| EP-0769549-A2 | Enzyme mutants having a low degree of variation of the molecular charge over a pH range | NOVO NORDISK A/S (DK) | 1997-04-23 | — | — | EP | disclosed |
| WO-1996012016-A1 | NEURONAL APOPTOSIS INHIBITOR PROTEIN, GENE SEQUENCE AND MUTATIONS CAUSATIVE OF SPINAL MUSCULAR ATROPHY | THE UNIVERSITY OF OTTAWA (CA) | 1996-04-25 | — | — | WO | disclosed |
| WO-1994023030-A2 | METHODS AND MATERIALS RELATING TO THE FUNCTIONAL DOMAINS OF DNA BINDING PROTEINS | ARCH DEVELOPMENT CORPORATION (US) | 1994-10-13 | — | — | WO | disclosed |
| EP-0563103-A1 | ENZYMES AND ENZYMATIC DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992011357-A1 | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE | NOVO NORDISK A/S (DK) | 1992-07-09 | — | — | WO | disclosed |
| WO-1992011348-A1 | ENZYMES AND ENZYMATIC DETERGENT COMPOSITIONS | UNILEVER N.V. (NL) | 1992-07-09 | — | — | WO | disclosed |